Andrew J. Armanino
CIK 1807550 · last filed 2026-06-03
Andrew J. Armanino is a corporate insider who has filed 40 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for BCAL, was dated Jun 3, 2026. Across all open-market trades the lifetime net is +$891.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.79M
3
40
$891.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCAL | Director | 191,845 | $19.77 | $3.79M | $0 | 7 | 2026-06-03 |
| California BanCorp (CALB) Delisted | Director | 0 | $25.09 | $0 | $60.6K | 23 | 2024-07-31 |
| Better Therapeutics, Inc. (BTTX) Delisted | Director | 745,452 | $0.04 | $33.2K | $831.2K | 10 | 2023-12-20 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | BCAL | Grant (A) | +3,196 | $0 | EDGAR |
| 2026-05-26 | BCAL | Grant (A) | +1,040 | $0 | EDGAR |
| 2026-02-24 | BCAL | Mixed | +1,082 | $763 | EDGAR |
| 2025-11-25 | BCAL | Grant (A) | +1,048 | $0 | EDGAR |
| 2025-08-22 | BCAL | Grant (A) | +1,214 | $0 | EDGAR |
| 2025-05-23 | BCAL | Grant (A) | +3,729 | $0 | EDGAR |
| 2024-08-12 | BCAL | Grant (A) | +3,146 | $0 | EDGAR |
| 2024-07-31 | California BanCorp (CALB) Delisted | Disp (D) | −135,096 | $0 | EDGAR |
| 2024-07-22 | California BanCorp (CALB) Delisted | Grant (A) | +1,399 | $0 | EDGAR |
| 2024-02-05 | California BanCorp (CALB) Delisted | Grant (A) | +482 | $12.0K | EDGAR |